Pathology and Molecular Pharmacology

Lab publications

  • Biochimica et Biophysica Acta

    01/07/2020

    Antiviral research

    Imiquimod Suppresses Respiratory Syncytial Virus (RSV) Replication via PKA Pathway and Reduces RSV Induced-Inflammation and Viral Load in Mice Lungs

    Franco Maximiliano Salinas, Antonela Díaz Nebreda, Luciana Vázquez, María Virginia Gentilini, Victoria Marini, Martina Benedetti, Mercedes Soledad Nabaes Jodar, Mariana Viegas, Carina Shayo, Carlos Alberto Bueno

  • Frontiers in Oncology

    21/02/2020

    Frontiers in Pharmacology

    The Regulator of G Protein Signaling Homologous Domain of G Protein-Coupled Receptor Kinase 2 Mediates Short-Term Desensitization of ?3-Adrenergic Receptor

    Echeverría E, Cabrera M, Burghi V, Sosa M, Ripoll S, Yaneff A, Monczor F, Davio C, Shayo C, Fernández N.

  • Molecular Pharmacology

    01/07/2019

    Molecular Pharmacology

    Identification of MRP4/ABCC4 as a target for reducing the proliferation of pancreatic ductal adenocarcinoma cells by modulating the camp efflux

    Carozzo A, Yaneff A, Gomez N, Di Siervi N, Sahores A, Diez F, Attorresi AI, Rodriguez-Gonzalez A, Monczor F, Fernandez N, Abba M, Shayo C, Davio C.

  • Biochimica et Biophysica Acta

    15/03/2019

    European journal of pharmacology

    Involvement of histamine H1 and H2 receptor inverse agonists in receptor’s crossregulation

    Díaz Nebreda A, Zappia CD, Rodríguez González A, Sahores A, Sosa M, Burghi V, Monczor F, Davio C, Fernández N, Shayo C.

  • Current Drug Targets

    01/01/2019

    Current Medicinal Chemistry

    MRP4/ABCC4 as a new therapeutic target: meta-analysis to determine cAMP binding sites as a tool for drug design

    Yaneff A, Sahores A, Gomez N, Carozzo A, Shayo C, Davio C.

  • 01/10/2018

    Hormones and Cancer

    Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer

    Sahores A, Figueroa V, May M, Liguori M, Rubstein A, Fuentes C, Jacobsen BM, Elía A, Rojas P, Sequeira GR, Álvarez MM, González P, Gass H, Hewitt S, Molinolo A, Lanari C, Lamb CA.

  • European Journal of Cancer

    01/03/2018

    European Journal of Cancer

    Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys

    Abiuso AMB, Varela ML, Haro Durand L, Besio Moreno M, Marcos A, Ponzio R, Rivarola MA, Belgorosky A, Pignataro OP, Berensztein E, Mondillo C

  • Biochimica et Biophysica Acta

    15/12/2017

    Biochemical Pharmacology

    Effect of mutation of Phe 2436.ar of the histamine H2 receptor on cimetidine and ranitidine mechanism of action

    Granja-Galeano G, Zappia CD, Fabián L, Davio C, Shayo C, Fernández N, Monczor F.

  • Current Drug Targets

    13/12/2017

    Current Cancer Drug Targets

    Targeting FGFR with BGJ398 in breast cancer: Effect on tumor growth and metastasis

    Sahores A, May M, Sequeira G, Fuentes C, Jacobsen B, Lanari C, Lamb CA.

  • Cells

    03/07/2017

    Materials

    In Vitro Human Umbilical Vein Endothelial Cells Response to Ionic Dissolution Products from Lithium-Containing 45S5 Bioactive Glass

    Haro Durand LA, Vargas GE, Vera-Mesones R, Baldi A, Zago MP, Fanovich MA, Boccaccini AR, Gorustovich A.